Sandoz continues to go through an exciting and transformative period as a global leader and pioneering provider of sustainable Biosimilar and Generic medicines. As we continue down this new and ambitious path, unique opportunities will present themselves, both professionally and personally. Join us, the future is ours to shape!
As part of the Security Architecture & Advisory team, the IAM Security Architect is responsible for designing and securing Sandoz’s Identity and Access Management landscape. This role plays a critical part in ensuring the confidentiality, integrity, and availability of IAM systems while supporting enterprise-wide initiatives and compliance requirements.
Your Key Responsibilities:
Your responsibilities include, but not limited to:
Lead architecture and design of IAM solutions (e.g., SailPoint Identity Now, MS Entra ID, CyberArk, PKI), ensuring scalability and security
Define and govern target IAM architecture aligned to enterprise standards
Ensure robust IAM integration across hybrid environments (cloud and on-prem systems)
Establish and enforce IAM security principles, standards, and guardrails
Conduct architecture and security assessments, identifying gaps and driving remediation strategies
Provide architectural guidance and design authority to delivery teams
Act as a senior IAM subject matter expert and advisor to leadership and stakeholders
Collaborate across Security, Infrastructure, and Business teams to support enterprise initiatives
KPI: Ensure high availability, compliance, and security posture of IAM systems
What you’ll bring to the role:
Essential Requirements:
University degree in computer science, engineering, IT, or related field
4+ years of experience as IAM / Identity Governance Solution Architect
Strong background in security architecture and governance design
Experience designing IAM solutions in complex enterprise environments
Hands-on experience with IAM capabilities such as MFA, SSO, identity lifecycle, federation, PAM
Strong stakeholder management skills across technical and business domains
Ability to translate regulatory requirements into scalable IAM designs
Experience working in global and cross-functional environments
Essential skills: Strong analytical, problem-solving, and communication skills with architectural mindset
Languages: Fluent written and spoken English
Desirable Requirements:
Knowledge of standards such as ISO 27001, CIS Controls, NIST, Cyber Essentials
Certifications such as CISSP, CISM, CISA, or relevant vendor certifications
You’ll receive:
Competitive compensation and benefits package
Flexible and hybrid working opportunities
Learning and development programs to enhance technical and leadership skills
Career growth opportunities within a global organization
Inclusive and collaborative work culture
Why Sandoz?
Generic and Biosimilar medicines are the backbone of the global medicines industry. Sandoz, a leader in this sector, provided more than 900 million patient treatments across 100+ countries in 2024 and while we are proud of this achievement, we have an ambition to do more!
With investments in new development capabilities, production sites, new acquisitions, and partnerships, we have the opportunity to shape the future of Sandoz and help more patients gain access to low-cost, high-quality medicines, sustainably.
Our momentum is powered by an open, collaborative culture driven by our talented and ambitious colleagues, who, in return for applying their skills experience an agile and collegiate environment with impactful, flexible-hybrid careers, where diversity is welcomed and where personal growth is supported!
Join us!
Skills Desired
Communication Skills, Cyber-Security Regulation, Cyber Threat Hunting, Cyber Threat Intelligence (Cti), Cyber Threat Management, Cyber Vulnerabilities, Decision Making Skills, Influencing Skills, Information Security Risk Management
Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients.
More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer.
Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion.
Read our community engagement guidelines: http://bit.ly/4ofoggc
